Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Heming

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Seminars in Respiratory and Critical Care Medicine|July 5, 2024
Acute Management of Sepsis beyond 24 HoursAntoine Premachandra, Nicholas Heming
JAMA|July 6, 2016
Acetazolamide and Invasive Mechanical Ventilation for Patients With COPD--ReplyChristophe Faisy, Nicholas Heming,
Critical Care (London, England)|August 8, 2012
Acetazolamide: a second wind for a respiratory stimulant in the intensive care unit?Nicholas Heming, Saïk Urien, Christophe Faisy
Critical Care (London, England)|September 16, 2011
Population pharmacodynamic model of bicarbonate response to acetazolamide in mechanically ventilated chronic obstructive pulmonary disease patientsNicholas Heming, Christophe Faisy, Saïk Urien
Critical Care (London, England)|April 5, 2011
Iron deficiency in critically ill patients: highlighting the role of hepcidinNicholas Heming, Philippe Montravers, Sigismond Lasocki
Expert Opinion on Emerging Drugs|January 12, 2016
Emerging drugs for the treatment of sepsisNicholas Heming, Laure Lamothe, Xavier Ambrosi, et al.
Journal of Clinical Medicine|May 13, 2023
Corticosteroids in ARDSEmmanuelle Kuperminc, Nicholas Heming, Miguel Carlos, et al.
Journal of Intensive Medicine|November 3, 2025
Corticosteroids in sepsisJihene Mahmoud, Marie Alice Bovy, Nicholas Heming, et al.
Frontiers in Immunology|August 15, 2018
Immune Effects of Corticosteroids in SepsisNicholas Heming, Sivanthiny Sivanandamoorthy, Paris Meng, et al.
Autoimmunity Reviews|December 4, 2012
Anti-inflammatory role of the IgA Fc receptor (CD89): from autoimmunity to therapeutic perspectivesSanae Ben Mkaddem, Elisabetta Rossato, Nicholas Heming, et al.
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Seminars in Respiratory and Critical Care Medicine|July 5, 2024
Acute Management of Sepsis beyond 24 HoursAntoine Premachandra, Nicholas Heming
JAMA|July 6, 2016
Acetazolamide and Invasive Mechanical Ventilation for Patients With COPD--ReplyChristophe Faisy, Nicholas Heming,
Critical Care (London, England)|August 8, 2012
Acetazolamide: a second wind for a respiratory stimulant in the intensive care unit?Nicholas Heming, Saïk Urien, Christophe Faisy
Critical Care (London, England)|September 16, 2011
Population pharmacodynamic model of bicarbonate response to acetazolamide in mechanically ventilated chronic obstructive pulmonary disease patientsNicholas Heming, Christophe Faisy, Saïk Urien
Critical Care (London, England)|April 5, 2011
Iron deficiency in critically ill patients: highlighting the role of hepcidinNicholas Heming, Philippe Montravers, Sigismond Lasocki
Expert Opinion on Emerging Drugs|January 12, 2016
Emerging drugs for the treatment of sepsisNicholas Heming, Laure Lamothe, Xavier Ambrosi, et al.
Journal of Clinical Medicine|May 13, 2023
Corticosteroids in ARDSEmmanuelle Kuperminc, Nicholas Heming, Miguel Carlos, et al.
Journal of Intensive Medicine|November 3, 2025
Corticosteroids in sepsisJihene Mahmoud, Marie Alice Bovy, Nicholas Heming, et al.
Frontiers in Immunology|August 15, 2018
Immune Effects of Corticosteroids in SepsisNicholas Heming, Sivanthiny Sivanandamoorthy, Paris Meng, et al.
Autoimmunity Reviews|December 4, 2012
Anti-inflammatory role of the IgA Fc receptor (CD89): from autoimmunity to therapeutic perspectivesSanae Ben Mkaddem, Elisabetta Rossato, Nicholas Heming, et al.
Pageof 8